Penn State's Eberly College of Science says the funding will help Schissel use AI to spot synthetic peptides useful for new drugs.
Recap by typeshit. Post by Penn State Eberly College of Science on X.
Researchers found the peptide they built as a treatment already circulates in human blood, at lower levels in people with cognitive impairment.
Lilly Medical points to newly published results from a double-blind, placebo-controlled phase 3 study of its triple-hormone shot in people with diabetes.
Topol points to work suggesting the body's own GLP-1 family peptides help reduce inflammation in the gut. Details are thin, so tap through for the study.
Medscape explores whether GLP-1 medicines might help keep people with schizophrenia out of the hospital. Tap through for the evidence behind the idea.
Reuters reports the FDA filed the change on Thursday, a formal step that could make it easier for pharmacies to compound some peptides now off limits.
BusinessWorld reports on a newer class of weight loss drugs that it says is beating Ozempic on results.
Loading…